Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir R Babaev

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Circulation|April 17, 2002
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient miceMichael E Burleigh, Vladimir R Babaev, John A Oates, et al.
Nature Medicine|June 1, 2001
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisLiza Makowski, Jeffrey B Boord, Kazuhisa Maeda, et al.
Biochemical Pharmacology|June 14, 2005
Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null miceMichael E Burleigh, Vladimir R Babaev, Mayur B Patel, et al.
Nature Medicine|December 8, 2009
Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosisEbru Erbay, Vladimir R Babaev, Jared R Mayers, et al.
Nature|June 8, 2007
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2Masato Furuhashi, Gürol Tuncman, Cem Z Görgün, et al.
American Journal of Physiology. Renal Physiology|March 4, 2011
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesityLi-Jun Ma, Bridgette A Corsa, Jun Zhou, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Circulation|April 17, 2002
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient miceMichael E Burleigh, Vladimir R Babaev, John A Oates, et al.
Nature Medicine|June 1, 2001
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisLiza Makowski, Jeffrey B Boord, Kazuhisa Maeda, et al.
Biochemical Pharmacology|June 14, 2005
Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null miceMichael E Burleigh, Vladimir R Babaev, Mayur B Patel, et al.
Nature Medicine|December 8, 2009
Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosisEbru Erbay, Vladimir R Babaev, Jared R Mayers, et al.
Nature|June 8, 2007
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2Masato Furuhashi, Gürol Tuncman, Cem Z Görgün, et al.
American Journal of Physiology. Renal Physiology|March 4, 2011
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesityLi-Jun Ma, Bridgette A Corsa, Jun Zhou, et al.
Pageof 4